• 1476 Citations
  • 19 h-Index
19952017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Adam Giermasz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Interleukin-12 Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Lovastatin Medicine & Life Sciences
Leukemia L1210 Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2017

  • 1476 Citations
  • 19 h-Index
  • 37 Article
  • 3 Letter
  • 3 Review article
1 Citation (Scopus)

A gap in comprehensive care: Sexual health in men with haemophilia

Tobase, P., Mahajan, A., Francis, D., Leavitt, A. D. & Giermasz, A., Jul 1 2017, In : Haemophilia. 23, 4, p. e389-e391

Research output: Contribution to journalLetter

Reproductive Health
Hemophilia A
142 Citations (Scopus)

Hemophilia B gene therapy with a high-specific-activity factor IX variant

George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J. M., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., McGuinn, C. E., Ragni, M. V., Luk, A. Y., Hui, D., Wright, J. F., Chen, Y., Liu, Y., Wachtel, K., Winters, A., Tiefenbacher, S. & 8 others, Arruda, V. R., Van Der Loo, J. C. M., Zelenaia, O., Takefman, D., Carr, M. E., Couto, L. B., Anguela, X. M. & High, K. A., Dec 7 2017, In : New England Journal of Medicine. 377, 23, p. 2215-2227 13 p.

Research output: Contribution to journalArticle

Hemophilia B
Factor IX
Coagulants
Genetic Therapy
Hemorrhage
11 Citations (Scopus)

Low-factor consumption for major surgery in haemophilia B with long-acting recombinant glycoPEGylated factor IX

Escobar, M. A., Tehranchi, R., Karim, F. A., Caliskan, U., Chowdary, P., Colberg, T., Giangrande, P., Giermasz, A., Mancuso, M. E., Serban, M., Tsay, W. & Mahlangu, J. N., Jan 1 2017, In : Haemophilia. 23, 1, p. 67-76 10 p.

Research output: Contribution to journalArticle

Hemophilia B
Factor IX
Hemostatics
Safety
Injections
18 Citations (Scopus)

Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine

Kono, M., Nakamura, Y., Suda, T., Uchijima, M., Tsujimura, K., Nagata, T., Giermasz, A., Kalinski, P., Nakamura, H. & Chida, K., Mar 30 2012, In : Vaccine. 30, 16, p. 2633-2639 7 p.

Research output: Contribution to journalArticle

dendritic cells
Dendritic Cells
Immunity
Vaccines
immunity
62 Citations (Scopus)

Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines

Giermasz, A., Urban, J. A., Nakamura, Y., Watchmaker, P., Cumberland, R. L., Gooding, W. & Kalinski, P., Aug 2009, In : Cancer Immunology, Immunotherapy. 58, 8, p. 1329-1336 8 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Interleukin-12
Dendritic Cells
Interleukin-4
Vaccines